Professional background

Dr Kate Young is a consultant medical oncologist at the Royal Marsden Hospital, specialising in renal and skin cancers, and is the unit lead for the acute oncology service. Kate studied at Cambridge University and undertook her clinical training at Imperial, qualifying in 2004. She trained as a junior doctor in London and completed specialist training in medical oncology at the Royal Marsden, where she was appointed a consultant in 2020. Kate completed an Md(res.) at the Institute of Cancer Research, where she is associate honorary faculty, and her research interests include survivorship and toxicities associated with immunotherapies. Kate chairs the new consultant groups for the Association of Cancer Physicians and for the UK Acute Oncology Society and leads the clinical support pillar for the Immuno-oncology Clinical Network.

Kate has an honorary contract with UCLH, where she is part of the immunotherapy neurotoxicity national advisory group and multidisciplinary team.

Research interests

Survivorship and immunotherapy toxicities